These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6133735)

  • 1. Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
    McDevitt DG
    Drugs; 1983 Apr; 25(4):331-8. PubMed ID: 6133735
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic receptor blocking drugs in hypertension.
    Simpson FO
    Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
    [No Abstract]   [Full Text] [Related]  

  • 3. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
    Aellig WH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):187S-192S. PubMed ID: 6125169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs.
    Shanks RG
    Eur Heart J; 1981 Jun; 2(3):253-5. PubMed ID: 6115754
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of beta-adrenoceptor blockade on left ventricular function.
    Hahn B; Strauer BE
    Br J Clin Pharmacol; 1982; 13(Suppl 2):305S-307S. PubMed ID: 6125181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blocking drugs.
    Gerber JG; Nies AS
    Annu Rev Med; 1985; 36():145-64. PubMed ID: 2581498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review.
    Reale A; Motolese M
    Eur Heart J; 1981 Jun; 2(3):245-51. PubMed ID: 6115753
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ; Beeley L
    Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy.
    Man in't Veld AJ; Boomsma F; Schalekamp MA
    Br J Clin Pharmacol; 1982; 13(Suppl 2):367S-374S. PubMed ID: 6125189
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases.
    Wayne VS; Harper RW; Laufer E; Federman J; Anderson ST; Pitt A
    Aust N Z J Med; 1982 Aug; 12(4):285-9. PubMed ID: 6127992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of partial beta-adrenoceptor agonist activity.
    Lipworth BJ; Grove A
    Br J Clin Pharmacol; 1997 Jan; 43(1):9-14. PubMed ID: 9056046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenoceptor-blocking drugs: current status and the significance of partial agonist activity.
    Louis WJ; McNeil JJ; Jarrott B; Drummer OH
    Am J Cardiol; 1983 Jul; 52(2):104A-107A. PubMed ID: 6135343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Typical risks in the treatment of chronic cardiac insufficiency].
    Bolte HD
    Internist (Berl); 1982 Mar; 23(3):133-7. PubMed ID: 6122662
    [No Abstract]   [Full Text] [Related]  

  • 17. [The principal beta-blockers. Undesirable effects and complications. General rules for their use].
    Libersa CC; Caron JF; Dupuis BA; Lekieffre JP
    Rev Prat; 1984 Apr; 34(19):923-39. PubMed ID: 6144160
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
    Greenblatt DJ; Koch-Weser J
    Drugs; 1974; 7(1):118-29. PubMed ID: 4151696
    [No Abstract]   [Full Text] [Related]  

  • 19. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?
    Bond RA; Spina D; Parra S; Page CP
    Pharmacol Ther; 2007 Sep; 115(3):360-74. PubMed ID: 17681610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.